Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regional variation in tolvaptan prescribing across England: national data and retrospective evaluation from an expert centre. | Clin Kidney J | 2023 | 36726434 | PubTator, text mining | PubMed |
| Early Commencement and Long-Term Continuation of Tolvaptan Treatment Attenuate Functional Impairment of Renal Vasopressin V2 Receptors and Improve Clinical Outcomes in Patients with Heart Failure. | Int Heart J | 2023 | 36725078 | PubTator, text mining | PubMed |
| Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial. | Clin J Am Soc Nephrol | 2023 | 36719158 | PubTator, text mining | PubMed |
| Health Disparities in Kidney Failure Among Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional Study. | Kidney Med | 2023 | 36718187 | PubTator, text mining | PubMed |
| Aquaporins in Diabetes Insipidus. | Adv Exp Med Biol | 2023 | 36717500 | PubTator, text mining | PubMed |
| Expression Regulation and Trafficking of Aquaporins. | Adv Exp Med Biol | 2023 | 36717485 | PubTator, text mining | PubMed |
| Generation of Gαi knock-out HEK293 cells illuminates Gαi-coupling diversity of GPCRs. | Commun Biol | 2023 | 36709222 | PubTator, text mining | PubMed |
| Polycystic Kidney Disease Drug Development: A Conference Report. | Kidney Med | 2023 | 36698747 | PubTator, text mining | PubMed |
| Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1). | Cell Rep | 2023 | 36680775 | PubTator, text mining | PubMed |
| The Urine Calcium/Creatinine Ratio and Uricemia during Hyponatremia of Different Origins: Clinical Implications. | J Clin Med | 2023 | 36675652 | PubTator, text mining | PubMed |
| The Role of Maxillofacial Structure and Malocclusion on Condylar Displacement in Maximum Intercuspation and Centric Relation in Patients Seeking Orthodontic Treatment-A Scoping Review. | J Clin Med | 2023 | 36675620 | PubTator, text mining | PubMed |
| Genome-Engineered mpkCCDc14 Cells as a New Resource for Studying AQP2. | Int J Mol Sci | 2023 | 36675199 | PubTator, text mining | PubMed |
| β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus. | Int J Mol Sci | 2023 | 36674662 | PubTator, text mining | PubMed |
| Advances in Aquaporins. | Cells | 2023 | 36672238 | PubTator, text mining | PubMed |
| Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice. | Mol Biol Rep | 2023 | 36662451 | PubTator, text mining | PubMed |
| Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently. | Life Sci Alliance | 2023 | 36650057 | PubTator, text mining | PubMed |
| N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases. | Kidney Int Rep | 2023 | 36644366 | PubTator, text mining | PubMed |
| Water-soluble extracellular vesicle probes based on conjugated oligoelectrolytes. | Sci Adv | 2023 | 36630497 | PubTator, text mining | PubMed |
| Associations of breast cancer related exposures and gene expression profiles in normal breast tissue-The Norwegian Women and Cancer normal breast tissue study. | Cancer Rep (Hoboken) | 2023 | 36617746 | PubTator, text mining | PubMed |
| Inhibition of mecA and blaCTX-M from MRSA and ESBL strains of diabetic foot infection by screening antibiotics compound library: an in silico analysis. | J Biomol Struct Dyn | 2023 | 36597915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=19